Rintatolimod

Rintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of chronic fatigue syndrome. However, there is only low-quality evidence that it can improve the people's ability to exercise.

It is a immunomodulatory double stranded RNA drug synthesized in the 1970s and manufactured by Hemispherx Biopharma.